DHJJ Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.5K Buy
825
+3
+0.4% +$172 0.01% 420
2026
Q1
$49.9K Buy
822
+3
+0.4% +$175 0.02% 399
2025
Q4
$44.2K Buy
819
+4
+0.5% +$192 0.01% 402
2025
Q3
$36.8K Buy
815
+34
+4% +$1.59K 0.01% 404
2025
Q2
$36.1K Buy
781
+267
+52% +$13.1K 0.01% 393
2025
Q1
$31.3K Hold
514
0.01% 379
2024
Q4
$29.1K Sell
514
-200
-28% -$11.2K 0.01% 377
2024
Q3
$36.9K Hold
714
0.01% 348
2024
Q2
$29.7K Sell
714
-50
-7% -$2.24K 0.01% 339
2024
Q1
$41.4K Hold
764
0.02% 288
2023
Q4
$39.2K Hold
764
0.02% 285
2023
Q3
$44.3K Buy
+764
New +$46.8K 0.02% 256

Other funds holding BMY

DHJJ Financial Advisors's BMY Position: Q2 2026 in Review

DHJJ Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.36% in Q2 2026, buying an estimated $172 and bringing the position to 825 shares worth $47.5K. The position accounts for 0.01% of the portfolio, ranked #420.

DHJJ Financial Advisors first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $49.9K in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • DHJJ Financial Advisors held 825 shares of Bristol-Myers Squibb worth $47.5K as of Q2 2026.
  • DHJJ Financial Advisors bought 3 Bristol-Myers Squibb shares in Q2 2026, an estimated $172.
  • Bristol-Myers Squibb made up 0.01% of DHJJ Financial Advisors's portfolio in Q2 2026, its #420 holding.
  • DHJJ Financial Advisors first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
  • DHJJ Financial Advisors's Bristol-Myers Squibb position peaked at $49.9K in Q1 2026.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on DHJJ Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.